Detalles de la búsqueda
1.
Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial.
Lancet
; 401(10394): 2113-2123, 2023 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220768
2.
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials.
Neth Heart J
; 32(6): 254-261, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38776038
3.
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.
Diabetes Obes Metab
; 24(7): 1277-1287, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35322567
4.
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial.
Catheter Cardiovasc Interv
; 98(2): E188-E196, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33694294
5.
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials.
Am Heart J
; 228: 109-115, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32882569
6.
Three contemporary thin-strut drug-eluting stents implanted in severely calcified coronary lesions of participants in a randomized all-comers trial.
Catheter Cardiovasc Interv
; 96(5): E508-E515, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32237060
7.
Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
Catheter Cardiovasc Interv
; 96(2): E110-E118, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31625262
8.
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.
Diabetes Obes Metab
; 22(9): 1607-1618, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32363737
9.
Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial.
Lancet
; 392(10154): 1235-1245, 2018 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30253879
10.
Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.
Heart Fail Rev
; 24(4): 499-510, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30848404
11.
Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial.
Am Heart J
; 198: 25-32, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29653644
12.
High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial.
Cardiovasc Drugs Ther
; 32(6): 567-576, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30143879
13.
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
Lancet
; 388(10060): 2607-2617, 2016 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27806902
14.
Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines.
Value Health
; 20(10): 1260-1269, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29241885
15.
Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial.
Am Heart J
; 176: 28-35, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27264217
16.
Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial.
Heart Vessels
; 31(11): 1731-1739, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26747438
17.
Urine measurement indicates the plasma brain natriuretic peptide concentration during optimization of heart failure treatment.
Scand J Clin Lab Invest
; 76(2): 112-7, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26577037
18.
Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial.
Lancet
; 383(9915): 413-23, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24183564
19.
Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial.
Am Heart J
; 169(1): 69-77, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25497250
20.
Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: insights from 2-year follow-up of the TWENTE trial.
Catheter Cardiovasc Interv
; 85(4): 524-31, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24753036